- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04267484
What Are my Options to Stay Safe at Home: Technology For Aging at Home (COORDINATEs)
Technology to Support Decision Making About Aging at Home (COORDINATEs)
Study Overview
Status
Intervention / Treatment
Detailed Description
This is a multi-phase study to be conducted in 3 countries: Canada (Quebec and Alberta), Sweden and Netherlands. The primary objective is to provide e-decision support technology that will facilitate self-management in the context of aging in place and foster informed value congruent decisions about options to age safely at home.
The aim of the project is to develop and validate a e-technology based on already existing components (e.g. GPS devices, diverse e-platforms and decision support interventions) to 1) help older adults with mild cognitive impairment/memory problems to stay safely at home as long as possible and 2) to provide older adults with decision support tools to help them make informed value congruent decisions (e.g. foster a shared decision-making process) regarding aging at home in a safe manner.
The secondary objectives are:
- Assess autonomy and mobility of older adults with mild cognitive impairment/memory problems living at home.
- Inform shared decision-making processes about options to safely age in place for all those involved.
The investigators will apply an integrated Knowledge Translation (iKT), comparative, mixed-methods approach to explore, older adults living at home with mild cognitive impairment/memory problems, their use of space in their homes and neighbourhoods.
The project is divide into 4 work package (WP). In more details, during WP1, the investigators will collect spatial data (e.g. using GPS) and self-reported data (e.g. travel diaries, walking interviews, in-depth interviews, surveys). At WP2, the investigators will use iterative end-user feedback and end-user consultation discussion group to tailor a decision support technology to knowledge-users. At WP3, investigators will assess user opinion regarding factors that could influence their use of the newly adapted e-decision support technology. Finally, at WP4 the investigators will triangulate data and take into account differences between jurisdictions.
This collaboration and our cross-country comparisons will contribute to scaling up e-decision support solutions in the future for the older adults with mild cognitive impairment/memory problems who want to age safely at home.
Study Type
Enrollment (Anticipated)
Contacts and Locations
Study Contact
- Name: France Légaré, PhD
- Phone Number: 8100 418-663-5919
- Email: francelegare@mfa.ulaval.ca
Study Contact Backup
- Name: Danielle Caron, PhD
- Phone Number: 418-663-5689
- Email: danielle.caro3.ciussscn@ssss.gouv.qc.ca
Study Locations
-
-
-
Edmonton, Canada
- Recruiting
- University of Alberta
-
Contact:
- Allyson Jones
-
-
Quebec
-
Québec, Quebec, Canada
- Recruiting
- CERSSPL
-
Contact:
- France Légaré, MD, PhD
-
-
-
-
-
Groningen, Netherlands
- Recruiting
- University of Groningen
-
Contact:
- Louise Meijering
-
-
-
-
-
Falun, Sweden
- Recruiting
- Dalarna University
-
Contact:
- Marie Elf
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Sampling Method
Study Population
Description
Inclusion Criteria:
- Aged ≥ 65 years
- Living at home
- Diagnosed with mild cognitive impairment or experiencing memory issues
- Able to read, understand and write
- Can provide informed consent
Exclusion Criteria:
- Older adults who are not able to provide informed consent
- Living in nursing home or hospital
Study Plan
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
---|---|
Older adults with mild cognitive impairment
WP1, older adults with cognitive impairment will use a GPS tracker for 2 weeks, during which they are asked 1) to keep a daily diary about their activity (travel diary), 2) take the researcher on a walk that they often do (walking interview), and 3) participate in an in-depth interview after 2 weeks, in which their experience with the GPS ans the travel diary data are discussed. WP2, older adults with mild cognitive impairment, caregivers, health professionals and technology developers will collaborate during group discussion meeting to co-design the e-decision support platform to be adapted. WP3, older adults with mild cognitive impairment, caregivers and health professionals will then be asked to use the adapted e-decision support platform and fill a survey. |
WP1: GPS tracker for 2 weeks and a daily diary about activity (travel diary).
WP2 and WP3: An e-decision support platform that will foster shared decision making about options to stay safe at home for the older adult.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Autonomy and mobility assessment using GPS
Time Frame: Participant will wear a GPS for a total of two weeks. As data collection will occur in parallel at all four sites (Quebec, Alberta, Sweden, Netherlands) data collection will happen over a period of 1 year
|
WP1: 1) Asses autonomy and mobility of older adults with mild cognitive impairment and memory problems living at home (including caregivers), their movement through their homes and neighborhoods (using GPS and walking interview); 2) how GPS data can support ongoing SDM about housing options for older adults.
|
Participant will wear a GPS for a total of two weeks. As data collection will occur in parallel at all four sites (Quebec, Alberta, Sweden, Netherlands) data collection will happen over a period of 1 year
|
Iterative assessment to tailor the e-decision support technology
Time Frame: Immediately after group discussion. 3 sequential group discussion are plan to occur, one in each country (Canada, Sweden, Netherlands) data collection will happen over a period of 1 year.
|
WP2: 1) Group discussion on if and how to incorporate GPS and adaptation of an existing e-platforms to create an adapted e-decision support technology (noted that the discussion focus will depend on result from WP1).
|
Immediately after group discussion. 3 sequential group discussion are plan to occur, one in each country (Canada, Sweden, Netherlands) data collection will happen over a period of 1 year.
|
User experience assessment of the newly adapted technology
Time Frame: Immediately after testing the new platform. As data collection will occur in parallel at all four sites (Quebec, Alberta, Sweden, Netherlands), it will happen over a period of 6 months
|
WP3: 1) Opinion of older adults with mild cognitive impairment, caregivers and health professionals about the adapted technology (noted that the final survey will depend on result from WP1 and WP2).
|
Immediately after testing the new platform. As data collection will occur in parallel at all four sites (Quebec, Alberta, Sweden, Netherlands), it will happen over a period of 6 months
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Inform SDM processes about housing option
Time Frame: 9 months
|
WP4: 1) Knowledge about differences and similarities between three countries
|
9 months
|
Open-ended questionnaire of participant global health status and their experience of using the GPS and filling the travel diary
Time Frame: Immediately before and after carrying the GPS at WP1. As data collection will occur in parallel at all four sites (Quebec, Alberta, Sweden, Netherlands) data collection will happen over a period of 1 year
|
WP1: Participant will be ask to share their experience with the GPS and the travel diary
|
Immediately before and after carrying the GPS at WP1. As data collection will occur in parallel at all four sites (Quebec, Alberta, Sweden, Netherlands) data collection will happen over a period of 1 year
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: France Légaré, PhD, Laval University
Publications and helpful links
General Publications
- Caron CD, Ducharme F, Griffith J. Deciding on institutionalization for a relative with dementia: the most difficult decision for caregivers. Can J Aging. 2006 Summer;25(2):193-205. doi: 10.1353/cja.2006.0033.
- Garvelink MM, Emond J, Menear M, Briere N, Freitas A, Boland L, Perez MMB, Blair L, Stacey D, Legare F. Development of a decision guide to support the elderly in decision making about location of care: an iterative, user-centered design. Res Involv Engagem. 2016 Jul 19;2:26. doi: 10.1186/s40900-016-0040-0. eCollection 2016.
- Pot AM, Willemse BM, Horjus S. A pilot study on the use of tracking technology: feasibility, acceptability, and benefits for people in early stages of dementia and their informal caregivers. Aging Ment Health. 2012;16(1):127-34. doi: 10.1080/13607863.2011.596810. Epub 2011 Jul 25.
- Greenhalgh T, Jackson C, Shaw S, Janamian T. Achieving Research Impact Through Co-creation in Community-Based Health Services: Literature Review and Case Study. Milbank Q. 2016 Jun;94(2):392-429. doi: 10.1111/1468-0009.12197.
- Meijering L, Weitkamp G. Numbers and narratives: Developing a mixed-methods approach to understand mobility in later life. Soc Sci Med. 2016 Nov;168:200-206. doi: 10.1016/j.socscimed.2016.06.007. Epub 2016 Jun 8.
- Sturge J, Meijering L, Jones CA, Garvelink M, Caron D, Nordin S, Elf M, Legare F. Technology to Improve Autonomy and Inform Housing Decisions for Older Adults With Memory Problems Who Live at Home in Canada, Sweden, and the Netherlands: Protocol for a Multipronged Mixed Methods Study. JMIR Res Protoc. 2021 Jan 21;10(1):e19244. doi: 10.2196/19244.
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Anticipated)
Study Completion (Anticipated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 118792
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Aging
-
Tuba MadenCompletedAging | Aging Problems | Aging Disorder
-
Radboud University Medical CenterNot yet recruitingAging | Aging Well | Immuno Aging
-
University of Santiago de CompostelaEuropean Regional Development Fund; Center for Industrial Technological Development...Completed
-
TruDiagnosticBlushield USANot yet recruitingAging | Aging Well
-
San Diego State UniversityCompleted
-
Lithuanian Sports UniversityCompletedAging | Healthy AgingLithuania
-
Amazentis SAproDERM GmbHCompleted
-
Northumbria UniversityUniversity of East AngliaSuspendedSleep | Aging | Healthy AgingUnited Kingdom
-
University of West AtticaNot yet recruiting
-
University of Santiago de CompostelaAgencia Estatal de Investigación, SpainRecruiting
Clinical Trials on GPS and travel diary
-
Emory UniversityCenters for Disease Control and PreventionCompleted
-
Tel-Aviv Sourasky Medical CenterUnknown
-
University of WaterlooUniversity of Mississippi Medical Center; Travel Health NetworkCompletedTravel MedicineCanada
-
Ganin Fertility CenterCompletedInfertility | Embryonic DevelopmentEgypt
-
Forschungsinstitut der Diabetes Akademie MergentheimCompleted
-
University Paris 7 - Denis DiderotCompleted
-
University Hospital, AngersInstitut de Formation en Education Physique et en Sport d'Angers/Les Ponts... and other collaboratorsCompletedHealthy VolunteersFrance
-
Ohio State University Comprehensive Cancer CenterCompletedSkin Cancer | Gastrointestinal Cancer | Neuroendocrine CarcinomaUnited States
-
University Hospital, GrenobleCompleted
-
University Medical Center GroningenCompleted